ORTHOFIX MEDICAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.24 USD | +1.65% |
|
+1.07% | -1.78% |
| 04-16 | Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer | CI |
| 04-12 | Orthofix Medical Inc. Announces Board Resignation | CI |
| Sales 2024 * | 791M 1.08B | Sales 2025 * | 847M 1.16B | Capitalization | 497M 679M |
|---|---|---|---|---|---|
| Net income 2024 * | -56M -76.5M | Net income 2025 * | -32M -43.72M | EV / Sales 2024 * | 0.63 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.59 x |
| P/E ratio 2024 * |
-8.98
x | P/E ratio 2025 * |
-16.3
x | Employees | 1,634 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.49% |
More Fundamentals
* Assessed data
More news
Latest transcript on Orthofix Medical Inc.
More recommendations
More press releases
| 1 day | +1.65% | ||
| 1 week | +1.07% | ||
| Current month | +1.85% | ||
| 1 month | -1.93% | ||
| 3 months | -6.17% | ||
| 6 months | +13.26% | ||
| Current year | -1.78% |
1 week
12.89
13.44
1 month
12.8214.67
Current year
12.3814.90
1 year
9.5821.60
3 years
9.5844.98
5 years
9.5857.85
10 years
9.5874.44
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 01-07 | |
Julie Andrews
DFI | Director of Finance/CFO | 52 | 01-14 |
Catherine Burzik
CHM | Chairman | 73 | 21-06-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Catherine Burzik
CHM | Chairman | 73 | 21-06-20 |
Jason M. Hannon
BRD | Director/Board Member | 52 | 20-06-07 |
Charles Kummeth
BRD | Director/Board Member | 63 | 12-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.27% | 27 M€ | -4.49% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 13.24 | +1.65% | 217,314 |
| 24-05-01 | 13.02 | +0.19% | 228,191 |
| 24-04-30 | 13 | -0.69% | 420,924 |
| 24-04-29 | 13.09 | +0.77% | 244,536 |
| 24-04-26 | 12.99 | -0.84% | 258,973 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm
More quotes
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.
Calendar
2024-05-06
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.24
USD
Average target price
18.47
USD
Spread / Average Target
+39.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.78% | 489M | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 67.52B | |
| +2.06% | 50.06B | |
| +9.43% | 45.67B | |
| +3.40% | 41B | |
| +3.04% | 26.73B | |
| +4.64% | 26.47B | |
| +15.23% | 25.05B |
- Stock Market
- Equities
- OFIX Stock
